Home Investors

Investors

Share price analysis

Investor resources

Documents and presentations

Investor news

The latest RNS releases

LATEST NEWS

Avacta Provides Q2 2025 Business Update Outlining Progress Against Strategic Objectives

02 Jul 2025 | Investors

Latest news

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

01 Jul 2025 | Investors | Therapeutics

Read the latest Avacta Annual Report and Accounts